Literature DB >> 8882417

Characterization of T cell receptor repertoire and anti-Ro/SSA autoantibodies in relation to sialadenitis of NOD mice.

K Skarstein1, M Wahren, E Zaura, M Hattori, R Jonsson.   

Abstract

Non-obese diabetic (NOD) mice develop sialadenitis which morphologically resembles the exocrinopathy in human Sjögren's syndrome (SS). The sialadenitis is characterized by focal infiltrates of inflammatory cells. Immunoenzyme staining (ABC-technique) and monoclonal antibodies defining CD4, CD8, CD11b, TCR alpha/beta, gamma/delta, V beta 2, V beta 4, V beta 6, V beta 7, V beta 8.1, 2, V beta 10b and V beta 11 were used to examine the infiltrating mononuclear cells (MNC) in salivary glands of NOD mice. TCR alpha beta + cells dominated clearly over TCR gamma delta + cells in the salivary glands. A predominance of CD4+ T-cells was identified, while a small population of CD8+ cells was found in the salivary gland infiltrates. CD11b+ mononuclear cells were sporadically seen within the salivary gland lesions. All different TCR V beta:s which were analysed appeared to be utilized at the site of MNC infiltration in salivary glands; although with various frequencies. The frequency pattern of V beta gene expression in salivary glands was V beta 8.1,2 (15%) > V beta 6 (12%) > V beta 4 (11%) > V beta 10b (5%) > V beta 11 (5%) = V beta 2 (5%) > V beta 7 (3%). Analysis of the TCR V beta utilization in corresponding lymph nodes revealed a quite similar frequency pattern as found in the salivary glands. Serum samples were also tested for anti-Ro52, Ro60 and anti-La antibodies with Western blot. Autoantibody production was limited to anti-Ro/SSA and 3/37 (8%) of the mice were found to produce anti-Ro52 kD antibodies. The degree of sialadenitis (focus score) appeared not to influence reactivity to the Ro52 kD protein.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8882417     DOI: 10.3109/08916939508995294

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  15 in total

Review 1.  Animal models of Sjögren's syndrome.

Authors:  Malin V Jonsson; Nicolas Delaleu; Roland Jonsson
Journal:  Clin Rev Allergy Immunol       Date:  2007-06       Impact factor: 8.667

2.  Temporal changes in salivary glands of non-obese diabetic mice as a model for Sjögren's syndrome.

Authors:  N Roescher; B M Lodde; J L Vosters; P P Tak; M A Catalan; G G Illei; J A Chiorini
Journal:  Oral Dis       Date:  2011-09-14       Impact factor: 3.511

3.  Reversible lacrimal gland-protective regulatory T-cell dysfunction underlies male-specific autoimmune dacryoadenitis in the non-obese diabetic mouse model of Sjögren syndrome.

Authors:  Scott M Lieberman; Portia A Kreiger; Gary A Koretzky
Journal:  Immunology       Date:  2015-06       Impact factor: 7.397

4.  TACI-Fc gene therapy improves autoimmune sialadenitis but not salivary gland function in non-obese diabetic mice.

Authors:  J L Vosters; N Roescher; G G Illei; J A Chiorini; P P Tak
Journal:  Oral Dis       Date:  2011-12-29       Impact factor: 3.511

5.  Elevated levels of cysteine protease activity in saliva and salivary glands of the nonobese diabetic (NOD) mouse model for Sjögren syndrome.

Authors:  C P Robinson; S Yamachika; C E Alford; C Cooper; E L Pichardo; N Shah; A B Peck; M G Humphreys-Beher
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-27       Impact factor: 11.205

6.  Selecting highly sensitive non-obese diabetic mice for improving the study of Sjögren's syndrome.

Authors:  Weibao Xiao; Yalan Wu; Jingfa Zhang; Wen Ye; Guo-Tong Xu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-09-23       Impact factor: 3.117

7.  STIM1 and STIM2 protein deficiency in T lymphocytes underlies development of the exocrine gland autoimmune disease, Sjogren's syndrome.

Authors:  Kwong Tai Cheng; Ilias Alevizos; Xibao Liu; Wiliam D Swaim; Hongen Yin; Stefan Feske; Masatsugu Oh-hora; Indu S Ambudkar
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-17       Impact factor: 11.205

Review 8.  The important role of T cells and receptor expression in Sjögren's syndrome.

Authors:  A Karabiyik; A B Peck; C Q Nguyen
Journal:  Scand J Immunol       Date:  2013-08       Impact factor: 3.487

Review 9.  Sjögren syndrome: what and where are we looking for?

Authors:  Cintia S de Paiva; Eduardo Melani Rocha
Journal:  Curr Opin Ophthalmol       Date:  2015-11       Impact factor: 3.761

10.  Protein kinase C expression in salivary gland acinar epithelial cells in non-obese diabetic mice, an experimental model for Sjögren's syndrome.

Authors:  E-K Tensing; J Ma; M Hukkanen; H S Fox; T-F Li; J Törnwall; Y T Konttinen
Journal:  Rheumatol Int       Date:  2003-09-12       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.